Kurt Geldhof

Neratinib after trastuzumab-based adjuvant therapy in HER2-positive breast cancer (ExteNET): 5-year analysis of a randomised, double-blind, placebo-controlled, phase 3 trial

Miguel Martín, Frankie A. Holmes, Bent Ejlertsen et al. · The Lancet Oncology · 2017 · 589 citations

Medicine, Oncology, Pharmacology +15

Serial comprehensive geriatric assessment in elderly head and neck cancer patients undergoing curative radiotherapy identifies evolution of multidimensional health problems and is indicative of quality of life

Lies Pottel, Michelle Lycke, Tom Boterberg et al. · European Journal of Cancer Care · 2014 · 98 citations

Medicine, Oncology, Radiation Oncology +15

G-8 indicates overall and quality-adjusted survival in older head and neck cancer patients treated with curative radiochemotherapy

Lies Pottel, Michelle Lycke, Tom Boterberg et al. · BMC Cancer · 2015 · 87 citations · Full text

Medicine, Oncology, Radiation Oncology +17

Determination of an adequate screening tool for identification of vulnerable elderly head and neck cancer patients treated with radio(chemo)therapy

Lies Pottel, Tom Boterberg, Hans Pottel et al. · Journal of Geriatric Oncology · 2011 · 68 citations

Medicine, Oncology, Radiation Oncology +16

Adequate iron chelation therapy for at least six months improves survival in transfusion-dependent patients with lower risk myelodysplastic syndromes

Michel Delforge, Dominik Selleslag, Yves Béguin et al. · Leukemia Research · 2014 · 66 citations

Medicine, Hematology, Pharmacology +16